• Nanocarrier-Mediated dsRNA Transdermal Delivery

  2026-09-08

  The reference study explains how a star cationic polymer helps dsRNA cross the insect cuticle by combining nanocomplex formation, wax-layer modification, improved wetting, and reduced resistance at the chitin layer. Its value is mechanistic: it connects carrier–cuticle interactions with transdermal RNAi performance while also defining important limits for transferring the approach to other insects and nanocarriers.

• ML216 and the Next Logic of RecQ-Targeted Translation

  2026-09-08

  ML216 is more than a biochemical BLM probe: it can help translational researchers connect helicase inhibition, homologous recombination stress, sister chromatid exchange, and tumor vulnerability. This thought-leadership analysis distinguishes BLM-directed evidence from the WRN–MSI findings reported in colorectal cancer, then proposes a disciplined path from enzyme assays to biomarker-led combination studies and xenograft validation.

• FPH1 (BRD-6125): From Function to Translation

  2026-09-07

  FPH1 (BRD-6125) offers a function-first strategy for expanding and evaluating human hepatocytes, while emerging light-controlled gene switches point toward more precisely regulated translational systems. This article connects assay design, hepatocyte biology, and translational strategy without implying that FPH1 and optogenetic platforms have yet been validated in combination.

• Merimepodib (VX-497) in IMPDH Research

  2026-09-07

  Merimepodib (VX-497) gives researchers a reversible way to probe guanine nucleotide dependence across antiviral, immunology, and cell-proliferation models. Its strongest use-case is a layered workflow that combines pharmacological inhibition with metabolic rescue, viability controls, and orthogonal IMPDH2 perturbation.

• Esflurbiprofen and Fast-Onset Antidepressant Action

  2026-09-05

  This study identifies esflurbiprofen as a preclinical fast-onset antidepressant candidate that disrupts the SERT–nNOS complex in the dorsal raphe nucleus. Its screening-to-mechanism workflow links PDZ-domain targeting with behavioral, imaging, and serotonergic readouts, while also clarifying the limits of translating these findings beyond the tested mouse models.

• 6-FAM SE: Designing Evidence-Ready Assays

  2026-09-04

  6-FAM SE enables durable amine-reactive labeling of proteins, peptides, DNA-associated probes, and modified nucleotides. This guide connects its reaction chemistry to assay design and extracts practical lessons from a glutathione-responsive nanomedicine study without conflating fluorescence tracking with therapeutic evidence.

• Cy7 NHS Ester: Practical NIR Labeling Guide

  2026-09-04

  Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared dye for covalent labeling of amino groups on proteins and peptides when organic cosolvents may be undesirable. It is appropriate for optimized labeling and imaging workflows, but dye solutions should be prepared fresh, and assay-specific performance, cellular compatibility, and in vivo behavior must be validated rather than assumed.

• IR-820: Designing Quantitative NIR Imaging Assays

  2026-09-03

  IR-820 (New Indocyanine Green) is more than an infrared signal source: it can be integrated into carefully controlled assays for vascular imaging, tumor localization, and diseased tissue quantification. This guide translates an ICG nanomedicine study into evidence-bounded decisions for IR-820-based in vivo imaging.

• Verapamil in Hypoxia-Driven Urothelial Inflammation

  2026-09-03

  Verapamil ((±)-Verapamil) is a practical pharmacological probe for separating short hypoxic stress from inflammation-competent exposure in urothelial cells. This guide translates duration-dependent HIF-1α, NO, ATP, and caspase-1 findings into a reproducible workflow while addressing solvent, dosing, and pathway-specific confounders.

• Site-Specific PEGylation Blocks IL-11 GP130 Signaling

  2026-09-02

  The reference study developed receptor-biased IL-11 analogs by placing a cysteine substitution at the GP130-binding interface and attaching PEG while largely preserving IL-11Rα recognition. In bleomycin-injured mice, the optimized PEGylated construct reduced extracellular matrix deposition, preserved alveolar structure, and extended IL-11 exposure, supporting site-specific PEGylation as both a pharmacokinetic and signaling-engineering strategy.

• Leucovorin Calcium in Gastric Assembloid Assays

  2026-09-02

  Leucovorin Calcium enables controlled folate rescue experiments that distinguish methotrexate-driven cytotoxicity from microenvironment-dependent drug response. Combined with patient-matched gastric tumor organoids and stromal cells, it supports more informative proliferation, viability, and antifolate resistance studies.

• C9orf72 Poly-GA, ERK1/2, and Tau Pathology

  2026-09-01

  The reference study identifies a mechanistic link between the C9orf72-derived poly-glycine-alanine dipeptide repeat protein (GA)50, ERK1/2 hyperphosphorylation, tau pathology, and cellular death. Pharmacological suppression with U0126 reduced these phenotypes, supporting ERK1/2 signaling as a possible mediator of poly-GA toxicity in C9ORF72-related frontotemporal lobar degeneration, while remaining subject to the limitations of a cellular model.

• Thioguanine: An Assay-First Research Guide

  2026-09-01

  Thioguanine and 6-thioguanine connect thiopurine metabolism, epigenetic regulation, and EV71 restriction. This assay-first guide explains how to translate mechanistic evidence into reliable antiviral and cancer research workflows.

• Tailored CAR Macrophages for Peritoneal Cancer

  2026-08-31

  Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal compartment. Screening 36 CAR architectures identified CD3ζ–TLR4 intracellular domains as a potent design, while single-cell analysis showed tumor-microenvironment remodeling and expansion of TCF1+PD-1+ progenitor-exhausted CD8+ T cells that may explain synergy with PD-1/L1 therapy.

• GPR35–KLF5 Signaling in Epithelial Repair

  2026-08-31

  The reference study identifies a tryptophan–kynurenine–kynurenic acid sensing mechanism in which GPR35 converts mucosal damage signals into KLF5-dependent epithelial repair. Its findings connect metabolite surveillance with PI3K–AKT–mTOR signaling, offering a mechanistic framework for interpreting barrier restoration in ulcerative colitis research and DSS-based models.

7994 records 1/533 page Next 12345 下5页 Last page